Literature DB >> 6100960

Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.

M Oren1, W Maltzman, A J Levine.   

Abstract

The 54K cellular tumor antigen has been translated in vitro, using messenger ribonucleic acids from simian virus 40 (SV40)-transformed cells or 3T3 cells. The in vitro 54K product could be immunoprecipitated with SV40 tumor serum and had a peptide map that was similar, but not identical, to the in vivo product. The levels of this 54K protein in SV3T3 cells were significantly higher than those detected in 3T3 cells (D. I. H. Linzer, W. Maltzman, and A. J. Levine, Virology 98:308-318, 1979). In spite of this, the levels of translatable 54K messenger ribonucleic acid from 3T3 and SV3T3 cells were roughly equivalent or often greater in 3T3 cells. Pulse-chase experiments with the 54K protein from 3T3 or SV3T3 cells demonstrated that this protein, once synthesized, was rapidly degraded in 3T3 cells but was extremely stable in SV3T3 cells. Similarly, in an SV40 tsA-transformed cell line, temperature sensitive for the SV40 T-antigen, the 54K protein was rapidly turned over at the nonpermissive temperature and stable at the permissive temperature, whereas the levels of translatable 54K messenger ribonucleic acid at each temperature were roughly equal. These results demonstrate a post-translational regulation of the 54K cellular tumor antigen and suggest that this control is mediated by the SV40 large T-antigen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6100960      PMCID: PMC369648          DOI: 10.1128/mcb.1.2.101-110.1981

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  24 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  The requirement of simian virus 40 gene A product for the stimulation of cellular thymidine kinase activity after viral infection.

Authors:  E H Postel; A J Levine
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

3.  Autoregulation of simian virus 40 gene A by T antigen.

Authors:  S I Reed; G R Stark; J C Alwine
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

4.  Organization and expression of early genes of simian virus 40.

Authors:  L V Crawford; C N Cole; A E Smith; E Paucha; P Tegtmeyer; K Rundell; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  Stimulation of RNA synthesis in isolated nucleoli by preparations of simian virus 40 T antigen.

Authors:  S Whelly; T Ide; R Baserga
Journal:  Virology       Date:  1978-07-01       Impact factor: 3.616

6.  Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.

Authors:  S A Aaronson; G J Todaro
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

7.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

8.  Stimulation of RNA synthesis in isolated nuclei by partially purified preparations of simian virus 40 T-antigen.

Authors:  T Ide; S Whelly; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

9.  Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen.

Authors:  C Prives; E Gilboa; M Revel; E Winocour
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens.

Authors:  E G Gurney; R O Harrison; J Fenno
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

View more
  160 in total

1.  Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.

Authors:  E Gottlieb; R Haffner; A King; G Asher; P Gruss; P Lonai; M Oren
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

Authors:  E Shaulian; A Zauberman; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 4.  Regulation by proteolysis: energy-dependent proteases and their targets.

Authors:  S Gottesman; M R Maurizi
Journal:  Microbiol Rev       Date:  1992-12

Review 5.  Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.

Authors:  Shailender Bhatia; Olga Afanasiev; Paul Nghiem
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

6.  Characterization of the human p53 gene promoter.

Authors:  S P Tuck; L Crawford
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

7.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.

Authors:  P Hinds; C Finlay; A J Levine
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.

Authors:  E Harlow; N M Williamson; R Ralston; D M Helfman; T E Adams
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

9.  Expression of p53 product in Chinese human bladder carcinoma.

Authors:  D W Ye; J F Zheng; S X Qian; Y J Ma
Journal:  Urol Res       Date:  1993-05

10.  Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.

Authors:  Yong-Sam Jung; Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.